M
Michael Flentje
Researcher at University of Würzburg
Publications - 380
Citations - 13487
Michael Flentje is an academic researcher from University of Würzburg. The author has contributed to research in topics: Radiation therapy & Cancer. The author has an hindex of 60, co-authored 357 publications receiving 12240 citations.
Papers
More filters
Journal ArticleDOI
Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
Rolf D. Kortmann,Joachim Kühl,Beate Timmermann,Uwe Mittler,Christian Urban,Volker Budach,Eckart Richter,Normann Willich,Michael Flentje,Frank Berthold,Slavc I,Johannes Wolff,Christoph Meisner,Otmar D. Wiestler,Nils Sörensen,Monika Warmuth-Metz,Michael Bamberg +16 more
TL;DR: Maintenance chemotherapy would seem to be more effective in low-risk medulloblastoma, especially in patients older than 6 years of age, and quality control of radiotherapy revealed correct treatment in more than 88% for dose prescription, more than 90% for coverage of target volume, and 98% for field matching.
Journal ArticleDOI
Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.
S. Staar,Volker Rudat,Hartmut Stuetzer,Andreas Dietz,Peter Volling,Michael Schroeder,Michael Flentje,Hans Edmund Eckel,Rolf-Peter Mueller +8 more
TL;DR: With accelerated radiotherapy, the efficiency of simultaneously given chemotherapy may be not as high as expected when compared to standard fractionated RT and should be given in radiotherapy regimen only with strong hematologic indication.
Journal ArticleDOI
Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients.
TL;DR: Stereotactic radiotherapy for lung tumors offers a very effective treatment option locally without significant complications in medically impaired patients who are not amenable to surgery.
Journal ArticleDOI
[German S3-Guideline "Diagnosis and Treatment of Esophagogastric Cancer"]
Markus Moehler,Se-E. Al-Batran,T. Andus,M. Anthuber,Jann Arends,Dirk Arnold,Daniela Aust,P. Baier,Gustavo B. Baretton,J. Bernhardt,H. Boeing,E. Böhle,Carsten Bokemeyer,Jan Bornschein,W. Budach,E. Burmester,K. Caca,Wa A. Diemer,Cf F. Dietrich,MP Ebert,A. Eickhoff,C. Ell,J. Fahlke,H. Feußner,Rainer Fietkau,Wolfgang Fischbach,W. Fleig,Michael Flentje,He E. Gabbert,Pr R. Galle,M. Geissler,Ines Gockel,U. Graeven,Lars Grenacher,S. Groß,Jt T. Hartmann,M. Heike,Volker Heinemann,B. Herbst,Thomas Herrmann,S. Höcht,Rd D. Hofheinz,Heinz Höfler,T. Höhler,Ah H. Hölscher,Markus Horneber,J. Hübner,J. R. Izbicki,R. Jakobs,Christian Jenssen,Stephan Kanzler,M. Keller,Ralf Kiesslich,G. Klautke,J. Körber,Bj J. Krause,C. Kuhn,Frank Kullmann,H. Lang,Hartmut Link,Florian Lordick,K. Ludwig,Manfred P. Lutz,R. Mahlberg,Peter Malfertheiner,S. Merkel,Helmut Messmann,Hj-J. Meyer,Stefan Mönig,P. Piso,Steffen Pistorius,R. Porschen,T. Rabenstein,P. Reichardt,K. Ridwelski,Christoph Röcken,I. Roetzer,P. Rohr,W. Schepp,Pm M. Schlag,RM Schmid,Heinz Schmidberger,Wh-H. Schmiegel,Hj-J. Schmoll,G. Schuch,Christoph Schuhmacher,Kerstin Schütte,W. Schwenk,Michael Selgrad,A. Sendler,J. Seraphin,T. Seufferlein,Michael Stahl,Hubert J. Stein,C. Stoll,Martin Stuschke,Andrea Tannapfel,R. Tholen,Peter C. Thuss-Patience,K. Treml,U. Vanhoefer,M Vieth,H. Vogelsang,D. Wagner,U. Wedding,A. Weimann,H. Wilke,Ch. Wittekind +107 more
TL;DR: Authors M. Moehler, S-E.
Journal ArticleDOI
Stereotactic Radiotherapy of Targets in the Lung and Liver
TL;DR: Hypofractionated stereotactic irradiation of targets in the lung and liver is a locally effective treatment with actuarial local control rates of 76% after 1 year and 61–76% after 2 years without relevant acute toxicity.